Search

everythinglearnresearchcommunity

for

Search:↓

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

TREM2 macrophages and unsaturated lipids contribute to acne inflammation.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Oxidative stress may worsen female pattern hair loss and could help track the disease and treatment.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

DNA methylation changes are linked to skin diseases with inflammation.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.